Abstract
The purpose of this study was to evaluate the effectiveness of our combined treatment regimen and to clarify the possible prognostic factors in sudden sensorineural hearing loss (SSNHL). In a retrospective chart review, the charts of 68 patients who matched the inclusion criteria of this study were evaluated. All patients were treated with a standard regimen including prednisone, dextran and piracetam between January 1998 and December 2001. Initial (at the beginning of therapy) and final (3 weeks after the beginning of therapy) audiograms were compared with respect to hearing improvement. Possible prognostic factors were also evaluated. Overall hearing improvement was determined as 54.4%. Sex was the only determined prognostic factor in this study. Females had a better prognosis. Our treatment regimen had no superiority to the reported spontaneous hearing recovery. Females seem to have a better prognosis.
Similar content being viewed by others
References
Alexiou C, Arnold W, Fauser C, Schratzenstaller B, Gloddek B, Fuhrmann S, Lamm K (2001) Sudden sensorineural hearing loss. Does application of glucocorticoids make sense? Arch Otolaryngol Head Neck Surg 127:253–258
Byl FM Jr (1984) Sudden hearing loss: 8-years experience and suggested prognostic table. Laryngoscope 94:647–661
Cinnamon U, Bendet E, Kronenberg J (2001) Steroids, carbogen or placebo for sudden hearing loss: a prospective double blind study. Eur Arch Otorhinolaryngol 258:477–480
Gersdorrf M, Franceschi D (1986) Value of piracetam in the treatment of sudden idiopathic deafness. Preliminary report. Ann Otolaryngol Chir Cervicofac 103:283–285
Gianoli GJ, Li JC (2001) Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 125:142–146
Grandis JR, Hirsch BE, Wagener MM (1993) Treatment of idiopathic sudden sensorineural hearing loss. Am J Otol 14:183–185
Haberkamp TJ, Tanyeri H (1999) Management of idiopathic sudden sensorineural hearing loss. Am J Otol 20:587–595
Harris I (1984) Sudden hearing loss: membrane rupture. Am J Otol 5:484–487
Hickenbottom SL, Grotta J (1998) Neuroprotective therapy. Semin Neurol 18:485–492
Kronenberg J, Almagor M, Bendet E, Kushnir D (1992) Vasoactive therapy versus placebo in the treatnent of sudden hearing loss: a double-blind clinical study. Laryngoscope 102:65–68
Mann W, Beck C (1986) Calcium antagonists in the treatment of sudden deafness. Arch Otorhinolaryngol 243:170–173
Mattox DE, Simmons FB (1977) Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 86:463–480
Moskowitz D, Lee KJ, Smith HW (1984) Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 94:664–666
Redleaf MI, Bauer CA, Gantz BJ, Hoffman HT, Mccabe BF (1995) Diatrizoate and dextran treatment of sudden sensorineural hearing loss. Am J Otol 16:295–303
Schweinfurth JM, Parnes SM, Very M (1996) Current concepts in the diagnosis and treatment of sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 253:117–121
Simmons FB (1979) The double-membrane break syndrome in sudden hearing loss. Laryngoscope 89:59–64
Stockmans F, Deberdt W, Nystrom A, Nystrom E, Stassen JM, Vermylen J, Deckmyn H (1998) Inhibitory effect of piracetam on platelet-rich thrombus formation in an animal model. Thromb Haemost. 79:222–227
Tucci DL, Farmer JC Jr, Kitch RD, Witsell DL (2002) Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir. Otol Neurotol 23:301–308
Whitaker S (1980) Idiopathic sudden hearing loss. Am J Otol 1:180–183
Wilkins SA, Mattox DE, Lyles A (1987) Evaluation of a shotgun regimen for sudden hearing loss. Otolaryngol Head Neck Surg 97:474–480
Wilson WR, Byl FM, Laird N (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol Head Neck Surg 106:772–776
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Samim, E., Kılıc, R., Ozdek, A. et al. Combined treatment of sudden sensorineural hearing loss with steroid, dextran and piracetam: experience with 68 cases. Eur Arch Otorhinolaryngol 261, 187–190 (2004). https://doi.org/10.1007/s00405-003-0659-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-003-0659-y